Myasthenia gravis constitutes chronic autoimmune disease that primarily targets the neuromuscular junction. This junction mediates the transfer of signals from nerves to muscles, enabling movement. In myasthenia gravis, the body's immune system erroneously attacks these receptors, leading weakness and fatigue in the motor units. The indications of